Sanofi – ‘6-K’ for 12/20/02

On:  Friday, 12/20/02, at 11:36am ET   ·   For:  12/20/02   ·   Accession #:  903423-2-845   ·   File #:  1-31368

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Report of a Foreign Private Issuer   —   Form 6-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Report of a Foreign Private Issuer                     3      8K 

6-K
1st Page of 3
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
 PURSUANT TO RULES 13a-16 OR 15d-16 OF
 THE SECURITIES EXCHANGE ACT OF 1934

For the Month of December 2002
 SANOFI-SYNTHELABO
(Exact name of registrant as specified in its charter)

174, avenue de France, 75013 Paris, FRANCE
(Address of principal executive offices)

   (Indicate by check mark whether the registrant files or will file
annual reports under cover Form 20-F or Form 40-F.)           

Form 20-F  X    Form 40-F 
             ---             ---

  (Indicate by check mark whether the registrant by furnishing the
   information contained in this Form is also thereby furnishing the
    information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.                              

Yes       No  X 
    ---      ---

     (If "Yes" is marked, indicate below the file number assigned to the
   registrant in connection with Rule 12g3-2(b): 82-_______________.

6-K
2nd Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 2nd
                                                                          [LOGO]

Investor Relations                                                              
                                                        Paris, December 19, 2002

 Hanspeter SPEK, Executive Vice President,
 takes responsibility for the Worldwide Operations
of Sanofi-Synthelabo

 Sanofi-Synthelabo reorganizes its Operations into 3 geographical areas:
Europe, North America and Intercontinental

   As from January 1, 2003, Hanspeter SPEK, Executive Vice President, will be in
charge of the Worldwide Operations of Sanofi-Synthelabo, and appointed    
Chairman of the U.S. subsidiary.                                          

  In order to face the new challenges of the pharmaceutical industry in a fast
changing environment, Sanofi-Synthelabo has decided to reorganize its     
Operations into 3 geographical areas, reporting to him :                  

-  Europe, with the appointment of Christian LAJOUX, as President, Europe.
Christian LAJOUX was previously Chairman and C.E.O. of the French   
    subsidiary. He will be assisted by Etienne JACOB, Senior Vice President,
Europe                                                              

-  Intercontinental, with the appointment of Gordon PROCTOR, as President,
Intercontinental. Gordon PROCTOR was previously C.E.O. of the U.S.  
subsidiary                                                          

-  North America, where Hanspeter SPEK will also act as President, North  
America, pending the appointment of a new President.                

All these appointments will be effective as from January 1, 2003.         

Investor Relations Department                                             
Philippe Goupit    Director of Investor Relations                         
Isabelle Laurent   Investor Relations Europe                              
Sanjay Gupta       Investor Relations US                                  

Contacts :                                                                
E-mail : investor-relations@sanofi-synthelabo.com                         
Europe                                  US                                
Tel : + 33 1 53 77 45 45                Tel.:   1 212 551 42 93           
Fax : + 33 1 53 77 42 96                Fax :   1 212 551 49 10           

6-K
Last Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 3rd
              SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the        
undersigned, thereunto duly authorized.                                         

Dated: December 20, 2002                                                        

           SANOFI-SYNTHELABO

                     By: /s/ Marie-Helene Laimay
                                         ---------------------------------------
                          Name:  Marie-Helene Laimay
                                Title: Senior Vice President and
                                     Chief Financial Officer

Dates Referenced Herein

				Referenced-On Page
This ‘6-K’ Filing		Date		First		Last			Other Filings
		1/1/03		2					None on these Dates
Filed on / For Period End:		12/20/02		3
		12/19/02		2
									List all Filings